← Back to headlines
Heron Therapeutics Inc. Price Target Reduced by H.C. Wainwright
H.C. Wainwright has reduced its price target for Heron Therapeutics, Inc. (HRTX) to $4. The article investigates the factors contributing to this downward revision.
19 May, 11:08 — 19 May, 11:08
Sources
Showing 1 of 1 sources
